Aptahem AB logo

APTA TO 5 - Aptahem AB News Story

SEK0.1 0.0  0.0%

Last Trade - 13/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £8.80m
Enterprise Value £6.35m
Revenue £n/a
Position in Universe 1622nd / 1831

BRIEF-Recipharm Partners With Aptahem For Formulation Of Apta-1 Drug Candidate

Tue 17th December, 2019 9:11am
Dec 17 (Reuters) - Recipharm AB (publ)  RECIb.ST :
    * PARTNERS WITH APTAHEM FOR FORMULATION OF APTA-1 DRUG
CANDIDATE
    * WILL DEVELOP AN INJECTABLE FORMULATION FOR UPCOMING PHASE
1
STUDY

Source text for Eikon:  ID:nWkr2bjPzK 
Further company coverage:  RECIb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.